Literature DB >> 20199597

Identification of residues within ligand-binding domain 1 (LBD1) of the Borrelia burgdorferi OspC protein required for function in the mammalian environment.

Christopher G Earnhart1, Delacy V Leblanc, Katie E Alix, Daniel C Desrosiers, Justin D Radolf, Richard T Marconi.   

Abstract

Borrelia burgdorferi outer surface protein C (ospC) is required for the establishment of infection in mammals. However, its precise function remains controversial. The biologically active form of OspC appears to be a homodimer. Alpha helix 1 and 1' of the apposing monomers form a solvent-accessible pocket at the dimeric interface that presents a putative ligand-binding domain (LBD1). Here we employ site-directed and allelic-exchange mutagenesis to test the hypothesis that LBD1 is a determinant of OspC function in the mammalian environment. Substitution of residues K60, E61 and E63 which line LBD1 resulted in the loss of infectivity or influenced dissemination. Analyses of the corresponding recombinant proteins demonstrated that the loss of function was not due to structural perturbation, impaired dimer formation or the loss of plasminogen binding. This study is the first to assess the involvement of individual residues and domains of OspC in its in vivo function. The data support the hypothesis that OspC interacts with a mammalian derived ligand that is critical for survival during early infection. These results shed new light on the structure-functions relationships of OspC and challenge existing hypotheses regarding OspC function in mammals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20199597      PMCID: PMC2917209          DOI: 10.1111/j.1365-2958.2010.07103.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  93 in total

1.  Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development.

Authors:  Eric L Buckles; Christopher G Earnhart; Richard T Marconi
Journal:  Clin Vaccine Immunol       Date:  2006-10

2.  OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine.

Authors:  Christopher G Earnhart; Richard T Marconi
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

3.  Co-evolution of the outer surface protein C gene (ospC) and intraspecific lineages of Borrelia burgdorferi sensu stricto in the northeastern United States.

Authors:  Oliver Attie; John F Bruno; Yun Xu; Dan Qiu; Benjamin J Luft; Wei-Gang Qiu
Journal:  Infect Genet Evol       Date:  2006-05-08       Impact factor: 3.342

4.  Identification of an ospC operator critical for immune evasion of Borrelia burgdorferi.

Authors:  Qilong Xu; Kristy McShan; Fang Ting Liang
Journal:  Mol Microbiol       Date:  2007-04       Impact factor: 3.501

5.  Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains.

Authors:  Christopher G Earnhart; Eric L Buckles; Richard T Marconi
Journal:  Vaccine       Date:  2006-08-08       Impact factor: 3.641

6.  Borrelia burgdorferi genetic markers and disseminated disease in patients with early Lyme disease.

Authors:  Kathryn L Jones; Lisa J Glickstein; Nitin Damle; Vijay K Sikand; Gail McHugh; Allen C Steere
Journal:  J Clin Microbiol       Date:  2006-10-11       Impact factor: 5.948

7.  Complementation of a Borrelia afzelii OspC mutant highlights the crucial role of OspC for dissemination of Borrelia afzelii in Ixodes ricinus.

Authors:  Volker Fingerle; Gereon Goettner; Lise Gern; Bettina Wilske; Ulrike Schulte-Spechtel
Journal:  Int J Med Microbiol       Date:  2007-01-30       Impact factor: 3.473

8.  Rapid clearance of Lyme disease spirochetes lacking OspC from skin.

Authors:  Kit Tilly; Aaron Bestor; Mollie W Jewett; Patricia Rosa
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

9.  Dual binding specificity of a Borrelia hermsii-associated complement regulator-acquiring surface protein for factor H and plasminogen discloses a putative virulence factor of relapsing fever spirochetes.

Authors:  Evelyn Rossmann; Peter Kraiczy; Pia Herzberger; Christine Skerka; Michael Kirschfink; Markus M Simon; Peter F Zipfel; Reinhard Wallich
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

10.  Analysis of the RpoS regulon in Borrelia burgdorferi in response to mammalian host signals provides insight into RpoS function during the enzootic cycle.

Authors:  Melissa J Caimano; Radha Iyer; Christian H Eggers; Cynthia Gonzalez; Elizabeth A Morton; Michael A Gilbert; Ira Schwartz; Justin D Radolf
Journal:  Mol Microbiol       Date:  2007-07-23       Impact factor: 3.501

View more
  38 in total

Review 1.  Diversity of the Lyme Disease Spirochetes and its Influence on Immune Responses to Infection and Vaccination.

Authors:  Jerilyn R Izac; Richard T Marconi
Journal:  Vet Clin North Am Small Anim Pract       Date:  2019-04-06       Impact factor: 2.093

2.  Epitope mapping of Borrelia burgdorferi OspC protein in homodimeric fold.

Authors:  Adam Norek; Lubomír Janda
Journal:  Protein Sci       Date:  2017-02-11       Impact factor: 6.725

3.  Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.

Authors:  Jerilyn R Izac; Andrew C Camire; Christopher G Earnhart; Monica E Embers; Rebecca A Funk; Edward B Breitschwerdt; Richard T Marconi
Journal:  Vaccine       Date:  2019-03-25       Impact factor: 3.641

4.  Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.

Authors:  Diane G Edmondson; Sabitha Prabhakaran; Steven J Norris; Amy J Ullmann; Joe Piesman; Marc Dolan; Christian Probst; Christiane Radzimski; Winfried Stöcker; Lars Komorowski
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

5.  OspC is potent plasminogen receptor on surface of Borrelia burgdorferi.

Authors:  Özlem Önder; Parris T Humphrey; Brian McOmber; Farida Korobova; Nicholas Francella; Doron C Greenbaum; Dustin Brisson
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

Review 6.  Genetic Manipulation of Borrelia Spp.

Authors:  Dan Drecktrah; D Scott Samuels
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

7.  Outer surface protein OspC is an antiphagocytic factor that protects Borrelia burgdorferi from phagocytosis by macrophages.

Authors:  Sebastian E Carrasco; Bryan Troxell; Youyun Yang; Stephanie L Brandt; Hongxia Li; George E Sandusky; Keith W Condon; C Henrique Serezani; X Frank Yang
Journal:  Infect Immun       Date:  2015-10-05       Impact factor: 3.441

8.  Genetic Transformation and Complementation.

Authors:  D Scott Samuels; Dan Drecktrah; Laura S Hall
Journal:  Methods Mol Biol       Date:  2018

Review 9.  Complement Evasion by Lyme Disease Spirochetes.

Authors:  Jon T Skare; Brandon L Garcia
Journal:  Trends Microbiol       Date:  2020-05-29       Impact factor: 17.079

10.  Identification of Borrelia burgdorferi ospC genotypes in canine tissue following tick infestation: implications for Lyme disease vaccine and diagnostic assay design.

Authors:  D V L Rhodes; C G Earnhart; T N Mather; P F M Meeus; R T Marconi
Journal:  Vet J       Date:  2013-08-17       Impact factor: 2.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.